Fighting disease with a smartwatch? That’s genius.
A Duke lab uses Al and machine learning to analyze data collected by devices such as smartwatches to ultimately predict and prevent outbreaks of RSV, COVID-19 and the flu.
Read MorePosted by Jodi Leese Glusco | Jan 24, 2024
A Duke lab uses Al and machine learning to analyze data collected by devices such as smartwatches to ultimately predict and prevent outbreaks of RSV, COVID-19 and the flu.
Read MorePosted by WRAL TechWire | Dec 19, 2023
The randomized, placebo-controlled study led by Duke Health researchers suggests that probiotics could be a relatively simple and inexpensive approach to treating people after a COVID exposure.
Read MorePosted by WRAL TechWire | Dec 13, 2023
Pfizer’s forecast for sales of its COVID-19 vaccine and treatment next year falls more than $5 billion short of the Wall Street consensus. The drugmaker’s sales tumbled in early morning trading.
Read MorePosted by WRAL TechWire | Sep 27, 2023
A new study finds state-run COVID testing sites do not meet accessibility standards – meaning that some members of the public, such as individuals who are blind or visually impaired, are not able to access all of the relevant information on the sites.
Read MorePosted by WRAL TechWire | May 11, 2023
As the COVID-19 pandemic officially ends today, Dr. Cameron Wolfe, an infectious disease specialist who served on the front lines of care at Duke, reflects on all that has transpired over the past three years.
Read MorePosted by WRAL TechWire | Dec 14, 2022
Long COVID leaves some people with long-term symptoms, but it can be deadly, too. It played a part in at least 3,544 deaths in the United States in the first 30 months of the Covid-19 pandemic, a new report says.
Read MorePosted by WRAL TechWire | Sep 9, 2022
As we learn to live with COVID, we will also have to adapt to the effects of long COVID, when symptoms such as fatigue, difficulty breathing and “brain fog” appear after COVID. In this commentary, I attempt to assess the risk to our labor markets from long COVID.
Read MorePosted by WRAL TechWire | Aug 4, 2022
The Duke Clinical Research Institute (DCRI) has been named the Clinical Trials Data Coordinating Center for large-scale national research studies aimed at understanding and improving the treatment of long COVID.
Read MorePosted by Jason Parker | Jul 20, 2022
A study co-authored by the CFO of Durham-based EmitBio modeled potential cost savings if its technology could be used to treat COVID-19.
Read More